Pharmaceutical Advertising Advisory Board

Last updated
Pharmaceutical Advertising Advisory Board
Formation1976;48 years ago (1976)
Headquarters Pickering, Ontario
Website https://www.paab.ca/

The Pharmaceutical Advertising Advisory Board (PAAB) is a Canadian not-for-profit organization based in Pickering, Ontario. Acting as a pseudo-regulatory body, PAAB offers review and pre-clearance services recognized by Health Canada to pharmaceutical companies and marketing agencies who wish to advertise directly to consumers and/or healthcare professionals. [1] [2] It is financed on a fee-for-service basis.

Contents

It works collaboratively with Health Canada, with the federal agency represented as an ex-oficio member on PAAB's board of directors. [3] [4]

History

PAAB originated in 1976 through a collaboration between the Pharmaceutical Manufacturing Association of Canada and the Canadian Medical Association. [1] [5] Within its first year, the organization had two staff members and had reviewed some 400 applications. As of July 1977, all advertisements printed in the Canadian Medical Association Journal carried the PAAB seal of approval following an examination of their quality and accuracy. [5] In 2004, PAAB's Patient Material Code was revised to include materials provided to patients by healthcare providers as well as adding regulations to standardize advertising over the internet. [1]

As of 2015, PAAB reported completing over 7,000 "first reviews" annually. [4]

Activities

Advertising materials for all health products in Canada that are intended for healthcare professionals are submitted for review and pre-clearance by PAAB, who prescribes the guidelines for direct marketing to this group. [6] Educational materials and other messaging directed towards consumers on prescription drugs and the medical conditions they treat are reviewed by PAAB and Advertising Standards Canada to ensure compliance with regulatory requirements. [2] While these reviews are not mandatory, PAAB is obligated to forward all safety-related complaints to Health Canada. [7]

Organization

Governance

Board of directors

PAAB is governed by a board of 12 members, including representation from industry associations Innovative Medicines Canada, BIOTECanada, Association of Medical Advertising Agencies, Canadian Association of Medical Publisher and Consumer Health Products Canada. [1] [8] [9]

Notable former members of the board include Susan Eng, former Chair of the Canadian Association of Retired Persons. [4]

Clients

Clients of PAAB include pharmaceutical companies and advertising agencies working on behalf of pharmaceutical interests. [1] [10]

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> United States federal agency

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

<span class="mw-page-title-main">Pfizer</span> American multinational pharmaceutical and biotechnology corporation

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).

<span class="mw-page-title-main">Pharmaceutical Research and Manufacturers of America</span> Trade group

Pharmaceutical Research and Manufacturers of America, formerly known as the Pharmaceutical Manufacturers Association, is a trade group representing companies in the pharmaceutical industry in the United States. Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. PhRMA is headquartered in Washington, DC.

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

Health Canada is the department of the Government of Canada responsible for national health policy. The department itself is also responsible for numerous federal health-related agencies, including the Canadian Food Inspection Agency (CFIA) and the Public Health Agency of Canada (PHAC), among others. These organizations help to ensure compliance with federal law in a variety of healthcare, agricultural, and pharmaceutical activities. This responsibility also involves extensive collaboration with various other federal- and provincial-level organizations in order to ensure the safety of food, health, and pharmaceutical products—including the regulation of health research and pharmaceutical manufacturing/testing facilities.

An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in 1983.

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company is a component of the Euro Stoxx 50 stock market index.

Pharmaceutical marketing is a branch of marketing science and practice focused on the communication, differential positioning and commercialization of pharmaceutical products, like specialist drugs, biotech drugs and over-the-counter drugs. By extension, this definition is sometimes also used for marketing practices applied to nutraceuticals and medical devices.

<span class="mw-page-title-main">Regulation of therapeutic goods</span> Legal management of drugs and restricted substances

The regulation of therapeutic goods, defined as drugs and therapeutic devices, varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level, or at both state and national levels by various bodies, as in Australia.

<span class="mw-page-title-main">Ranitidine</span> Medication that decreases stomach acid

Ranitidine, sold under the brand name Zantac among others, is a medication used to decrease stomach acid production. It is commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. It can be given by mouth, injection into a muscle, or injection into a vein. In September 2019, the probable carcinogen N-nitrosodimethylamine (NDMA) was discovered in ranitidine products from a number of manufacturers, resulting in recalls.

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

<span class="mw-page-title-main">Off-label use</span> Use of pharmaceuticals for conditions different from that for which they were approved

Off-label use is the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration. Both prescription drugs and over-the-counter drugs (OTCs) can be used in off-label ways, although most studies of off-label use focus on prescription drugs.

Continuing medical education (CME) is continuing education (CE) that helps those in the medical field maintain competence and learn about new and developing areas of their field. These activities may take place as live events, written publications, online programs, audio, video, or other electronic media. Content for these programs is developed, reviewed, and delivered by faculty who are experts in their individual clinical areas. Similar to the process used in academic journals, any potentially conflicting financial relationships for faculty members must be both disclosed and resolved in a meaningful way. However, critics complain that drug and device manufacturers often use their financial sponsorship to bias CMEs towards marketing their own products.

An online pharmacy, internet pharmacy, or mail-order pharmacy is a pharmacy that operates over the Internet and sends orders to customers through mail, shipping companies, or online pharmacy web portal.

<span class="mw-page-title-main">Association of the British Pharmaceutical Industry</span> British trade group

The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. It is the British equivalent of America's PhRMA; however, the member companies research, develop, manufacture and supply medicines prescribed for the National Health Service.

Direct-to-consumer advertising (DTCA) refers to the marketing and advertising of pharmaceutical products directly to consumers as patients, as opposed to specifically targeting health professionals. The term is synonymous primarily with the advertising of prescription medicines via mass media platforms—most commonly on television and in magazines, but also via online platforms.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

The pharmaceutical industry in Russia had a turnover of $16.5 billion in 2016, which was equal to 1.3 % of GDP and 19.9% of health spending.

<span class="mw-page-title-main">Innovative Medicines Canada</span> Association of pharmaceutical companies

Innovative Medicines Canada (IMC) is a national association of pharmaceutical companies that represents the interests of the research-based pharmaceutical industry in Canada. Its membership includes biopharmaceutical companies, vaccine developers, and manufacturers of medical devices, and works with government agencies, insurance companies, healthcare professionals and other stakeholders in the regulation and promotion of medicines.

BIOTECanada, or the Industrial Biotechnology Association of Canada, is a Canadian biotechnology industry association based in Ottawa, Ontario. It is an industry-funded membership organization composed of over 250 national and international pharmaceutical and gene therapy companies, medical device manufacturers, agricultural science businesses, law firms, academic institutions, research and development networks, advertising agencies, insurance companies and financial services firms.

References

  1. 1 2 3 4 5 "PAAB : About". Pharmaceutical Advertising Advisory Board / Conseil Consultatif de Publicité Pharmaceutique. Archived from the original on 2018-09-24. Retrieved 2022-08-29.
  2. 1 2 Health Canada (2015-05-12). "Regulatory Requirements for Advertising". Government of Canada . Archived from the original on 2022-08-29. Retrieved 2022-08-29.
  3. Hearn, Bill; Zborovski, Sara (2015-07-07). "The International Comparative Legal Guide To Pharmaceutical Advertising". Mondaq . Retrieved 2022-09-01.
  4. 1 2 3 Khambatta, Richard; Integrated Pharma Services (July 2015). "PAAB Preclearance Review Mechanism: Audit Report Summary" (PDF). Pharmaceutical Advertising Advisory Board. Archived (PDF) from the original on 2022-09-01. Retrieved 2022-09-01.
  5. 1 2 Geekie, D.A. (1977-05-07). "Pharmaceutical Advertising Advisory Board and advertising in the Journal". Canadian Medical Association Journal. 116 (9): 968. ISSN   0008-4409. PMC   1879061 . PMID   20312852.
  6. Harris, Kelly (2020-03-31). "In brief: prohibited and controlled advertising in Canada". Lexology. Archived from the original on 2022-08-30. Retrieved 2022-08-30.
  7. Dakin, Pauline (2014-12-10). "Prescription drug ad law notable for 'lack of teeth'". CBC News . Archived from the original on 2014-12-11. Retrieved 2022-08-29.
  8. Lexchin, Joel (2018-04-12). "How Big Pharma deceives you about drug safety". The Conversation . Archived from the original on 2021-10-16. Retrieved 2022-08-30.
  9. Kingston, Anne (2018-05-11). "A criminal investigation into opioid marketing would expose larger systemic rot". Maclean's . Archived from the original on 2022-08-30. Retrieved 2022-08-30.
  10. "PAAB : About". Pharmaceutical Advertising Advisory Board. Archived from the original on 2018-01-08. Retrieved 2022-08-30.{{cite web}}: CS1 maint: unfit URL (link)